Arbe Announces Q3 2024 Financial Results

TEL AVIV, Israel, Nov. 27, 2024 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE) ("Arbe"), a global leader in Perception Radar Solutions, today announced financial results for its third quarter, ended September 30, 2024.

 

Arbe_Robotics_Logo

 

Key Q3 and Recent Company Highlights:

•  OEM Engagements: 

- Arbe experienced significant growth in both the number and the depth of our OEM engagements. The company is in active process with 16 OEMs, 12 of which progressed to the bid stage, and 8 entered the advanced perception project phase.

- Arbe collaborated with a leading European truck manufacturer, which plans to incorporate Arbe's radar chipset into its next-generation sensor suite.

•  Collaborations with Tier-1s:

HiRain Technologies accelerated the development of an ADAS system for a Chinese OEM, with the aim of replacing LiDAR with Arbe's radar chipset.

Sensrad signed a framework agreement to supply 4D imaging radars, powered by Arbe's technology, to Tianyi Transportation Technology in China.

•  Growing Market Demand: Arbe observed increasing interest in its radar technology from emerging verticals beyond automotive and is actively working with customers to address these opportunities.

•  Successful Capital Raise: Arbe completed an offering of up to $49 million, of which $15 million were received upfront and up to $34 million will be received upon the exercise in full for cash of long-term and milestone-linked warrants. The public offering was led by existing investor AWM Investment Company Inc. and joined by new investors. The proceeds will support the planned production ramp-up in 2025. Canaccord Genuity served as the sole bookrunner, with Roth Capital Partners acting as co-manager.

"This quarter, we made significant progress in testing and deliveries for leading European OEMs," said Kobi Marenko, Chief Executive Officer. "While the selection process has taken longer than anticipated, we remain on track toward achieving our design-in objectives. We are proud to have completed a public offering, welcoming both new and existing investors. This investment demonstrates their confidence in our progress and long-term vision. 
In Q3, we achieved important milestones with our Tier-1s HiRain and Sensrad. With HiRain, we are enhancing global automotive safety by providing radar capabilities traditionally associated with other sensor technologies. Sensrad's recent agreement underscores the growing demand for advanced innovative radar solutions across industries beyond automotive."

Third Quarter 2024 Financial Highlights

Revenues for Q3 2024 were $0.1 million, a decrease from $0.5 million in Q3 2023. Backlog as of September 30, 2024, was $0.5 million.

Negative gross profit for Q3 2024 was $0.3 million, compared to a positive gross profit of $0.1 million / 24% in Q3 2023, mainly related to the reduction in revenue with a fixed cost level of expenses.

Operating expenses in Q3 2024 were $12.2 million, compared to $11.7 million in Q3 2023. The increase in operating expenses was primarily driven by an increased investment in outsourced support (both in headcount and overall expenses) as well as an increase in our internal workforce.

Net loss in the third quarter of 2024 increased to $12.6 million, compared to a net loss of $11.7 million in the third quarter of 2023. Net loss in Q3 2024 included $0.1 million of financial expenses, including bond revaluations partially offset by interest deposit gains.

Adjusted EBITDA, a non-GAAP measurement which excludes expenses for non-cash share-based compensation and for non-recurring items, for Q3 2024, yielded a loss of $8.2 million, compared to a loss of $7.5 million in the third quarter of 2023.

Balance Sheet & Liquidity

As of September 30, 2024, Arbe had $19.1 million in cash and cash equivalents.

Outlook

  • Our goal of achieving 4 design-ins with automakers remains unchanged, as we observe continued strong interest in our market-leading offering.
  • We have strengthened our position in all our RFQ engagements, even though the OEMs have shifted their decision timelines from late 2023 to 2024.
  • The 2024 annual revenues are expected to be in line with those of 2023, followed by revenue growth in 2025. These revenue projections are based on the intention to be in full production in the second half of 2024, as well as our decision to exclusively focus on getting our chipset into production.
  • We are committed to maintaining a strong and well-managed balance sheet, focusing on cost-effectiveness and the ability to fund our revenue growth. Adjusted EBITDA for 2024 is projected to be in the range of ($30) million to ($36) million.

Conference Call & Webcast Details

Arbe will host a conference call and webcast today at 8:30 am ET. Speakers will include Kobi Marenko, Chief Executive Officer, Co-Founder and Director, and Karine Pinto-Flomenboim, Chief Financial Officer. The Company encourages participants to pre-register for the conference call here. Callers will receive a unique dial-in upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

The live call may be accessed via telephone at:

Toll Free: 1-(844) 481-3015

Israel Toll Free: 1-809-212373

Internationally: 1-(412) 317-1880

A telephonic replay of the conference call will be available until December 11, 2024, following the end of the conference call. To listen to the replay, please dial:

U.S. Toll Free: 1-877-344-7529
International: 1-412-317-0088
Access ID: 5174719

A live webcast of the call can be accessed here or from Arbe's Investor Relations website at https://ir.arberobotics.com/news/ir-calendar. An archived webcast of the conference call will also be made available on the website following the call.

Arbe (Nasdaq, TASE: ARBE), a global leader in Perception Radar Solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems today while paving the way to full autonomous-driving. Arbe's radar technology is 100 times more detailed than any other radar on the market and is a critical sensor for L2+ and higher autonomy. The company is empowering automakers, Tier-1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. Arbe, a leader in the fast-growing automotive radar market, is based in Tel Aviv, Israel, and has offices in China, Germany, and the United States.

Cautionary Note Regarding Forward-Looking Statements

This press release contains, and the webcast will contain "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, our ability to meet the milestones for the balance of our equity financing, the effect on the Israeli economy generally and on the Company's business resulting from the terrorism and the hostilities in Israel and with its neighboring countries including the effects of the continuing war with Hamas and any further intensification of hostilities with others, including Iran and Hezbollah, and the effect of the call-up of a significant portion of its working population, including the Company's employees; the effect of any potential boycott both of Israeli products and business and of stocks in Israeli companies; the effect of any downgrading of the Israeli economy and the effect of changes in the exchange rate between the US dollar and the Israeli shekel; and the risk and uncertainties described in "Cautionary Note Regarding Forward-Looking Statements," "Item 3. Key Information – D. Risk Factors" and "Item 5. Operating and Financial Review and Prospects" and in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on March 28, 2024, as well as other documents filed by the Company with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Information contained on, or that can be accessed through, the Company's website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.

 

 

CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands)







 Sep 30, 2024 


December 31, 2023

Current Assets:


 (Unaudited) 


 (Unaudited) 

Cash and cash equivalents


18,788


28,587

Restricted cash


280


163

Short term bank deposits


20


15,402

Trade receivable 


618


1,258

Other assets


30,417


-

Prepaid expenses and other receivables


2,114


2,026

Total current assets


52,237


47,436






Non-Current Assets





Operating lease right-of-use assets


1,800


1,740

Property and equipment, net


1,429


1,309

Total non-current assets


3,229


3,049






Total assets


55,466


50,485






Current liabilities:





Trade payables


942


1,149

Operating lease liabilities


524


436

Employees and payroll accruals


3,096


2,916

Convertible bonds


30,836


-

Accrued expenses and other payables 


871


1,710

Total current liabilities


36,269


6,211






Long term liabilities





Operating lease liabilities


1,443


1,306

Warrant liabilities


540


875

Total long-term liabilities


1,983


2,181






SHAREHOLDERS' EQUITY:





Ordinary Shares


 *) 


*)

Additional paid-in capital


257,976


245,733

Accumulated Deficit


(240,762)


(203,640)

Total shareholders' equity


17,214


42,093






Total liabilities and shareholders' equity


55,466


50,485






*) Represents less than $1.





 

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. dollars in thousands, except share and per share data)




 3 Months Ended 


3 Months Ended


9 Months Ended


9 Months Ended



 Sep 30, 2024 


 Sep 30, 2023 


 Sep 30, 2024 


 Sep 30, 2023 



 (Unaudited) 


(Unaudited)


(Unaudited)


(Unaudited)

Revenues


123


479


669


1,123

Cost of revenues


394


364


1,245


971

Gross profit (loss)


(271)


115


(576)


152










Operating Expenses:









Research and development, net


8,762


8,421


26,072


25,636

Sales and marketing


1,426


1,264


4,243


3,666

General and administrative


1,988


1,993


5,927


5,637

Total operating expenses


12,176


11,678


36,242


34,939










Operating loss


(12,447)


(11,563)


(36,818)


(34,787)










Financial expenses (income), net


127


134


303


(573)










Net loss


(12,574)


(11,697)


(37,121)


(34,215)










Basic net loss per ordinary share 


(0.16)


(0.15)


(0.46)


(0.49)










Weighted-average number of
shares used in computing basic
net loss per ordinary share 


80,957,931


77,474,326


79,914,649


69,975,104










Diluted net loss per ordinary share 


(0.19)


(0.18)


(0.58)


(0.56)










Weighted-average number of
shares used in computing diluted
net loss per ordinary share 


66,586,095


67,286,305


64,503,654


61,452,569

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS




(U.S. dollars in thousands)














 3 Months Ended 


3 Months Ended


9 Months Ended


9 Months Ended






 Sep 30, 2024 


 Sep 30, 2023 


 Sep 30, 2024 


 Sep 30, 2023 




Cash flows from operating activities:


 (Unaudited) 


(Unaudited)


(Unaudited)


(Unaudited)




Net Loss 


(12,574)


(11,697)


(37,121)


(34,215)
















Adjustments to reconcile loss to net cash used in operating activities:












Depreciation


148


139


437


415




Stock-based compensation


3,800


3,707


11,399


9,428




Warrants to service providers


291


178


639


432



-

Revaluation of warrants and accretion


(67)


(252)


(335)


(490)




Revaluation of convertible bonds accretion


117


-


140


-




Change in operating assets and liabilities:












Decrease in trade receivable 


76


24


640


186




Decrease (increase) in prepaid expenses and other receivables 


(160)


58


(88)


562




Decrease in other assets 


128


-


-


-




Issuance costs related to convertible bonds


737


-


737


-




Operating lease ROU assets and liabilities, net


31


(5)


165


(4)




Increase (decrease) in trade payables 


85


(368)


(231)


(652)




Increase (decrease) in employees and payroll accruals


(169)


210


180


(340)




Decrease in accrued expenses and other payables


(225)


(83)


(839)


(3,789)
















Net cash used in operating activities


(7,782)


(8,089)


(24,277)


(28,467)
















Cash flows from investing activities:












Change in bank deposits


17,663


(13)


15,382


(25,215)




Purchase of property and equipment


(119)


(71)


(533)


(190)
















Net cash provided by (used in) investing activities


17,544


(84)


14,849


(25,405)
















Cash flows from financing activities:












Proceeds from issuance of ordinary shares, net of issuance costs 


-


-


-


22,496




Issuance costs related to convertible bonds


-


-


(459)


-




Proceeds from exercise of options


185


97


205


703
















Net cash provided by (used in) financing activities


185


97


(254)


23,199
















Effect of exchange rate fluctuations on cash and cash equivalent


(17)


(655)


197


(721)
















Increase (decrease) in cash, cash equivalents and restricted cash 


9,964


(7,421)


(9,879)


(29,952)




Cash, cash equivalents and restricted cash at the beginning of period


9,120


31,718


28,750


54,315
















Cash, cash equivalents and restricted cash at the end of period


19,068


23,642


19,068


23,642




 

 

RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS 

(U.S. dollars in thousands, except share and per share data)




















 3 Months Ended 


3 Months Ended


9 Months Ended


9 Months Ended



 Sep 30, 2024 


 Sep 30, 2023 


 Sep 30, 2024 


 Sep 30, 2023 

GAAP net loss attributable to ordinary shareholders


(12,574)


(11,697)


(37,121)


(34,215)










Add:









Stock-based compensation


3,800


3,707


11,399


9,428

Warrants to service providers


291


178


639


432

Revaluation of warrants and accretion


(67)


(252)


(335)


(490)

Convertible bonds accretion


117


-


140


-

Non-recurring expenses related to convertible bonds and ATM


-


-


805


214










Non-GAAP net loss


(8,433)


(8,064)


(24,473)


(24,631)










Basic Non-GAAP net loss per ordinary share 


(0.10)


(0.10)


(0.31)


(0.35)










Weighted-average number of shares used in computing
basic Non-GAAP net loss per ordinary share


80,957,931


77,474,326


79,914,649


69,975,104










Diluted Non-GAAP net loss per ordinary share 


(0.13)


(0.12)


(0.38)


(0.40)










Weighted-average number of shares used in computing
diluted Non-GAAP net loss per ordinary share 


66,586,095


67,286,305


64,503,654


61,452,569










RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA

(U.S. dollars in thousands)




















 3 Months Ended 


3 Months Ended


9 Months Ended


9 Months Ended



 Sep 30, 2024 


 Sep 30, 2024 


 Sep 30, 2024 


 Sep 30, 2024 

GAAP net loss attributable to ordinary shareholders


(12,574)


(11,697)


(37,121)


(34,215)










Add:









Financial expenses (income), net


127


134


303


(573)

Depreciation 


148


139


437


415

Stock-based compensation


3,800


3,707


11,399


9,428

Warrants to service providers


291


178


639


432

Non-recurring expenses related to ATM


-


-


68


214










Adjusted EBITDA 


(8,208)


(7,539)


(24,275)


(24,299)

Logo - https://mma.prnewswire.com/media/803813/Arbe_Robotics_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/arbe-announces-q3-2024-financial-results-302317412.html

SOURCE Arbe